Fractional Er:YAG Laser and 0.01% Bimatoprost in Leucoderma From Iatrogenic Melasma Treatment in a Skin Phototype V Patient
Dermatol Surg
.
2023 Sep 1;49(9):899-901.
doi: 10.1097/DSS.0000000000003868.
Epub 2023 Jun 29.
Authors
Sasima Eimpunth
1
,
Sarun Pacharapakornpong
1
,
Yuri Yogya
1
,
Margaret A Weiss
2
3
Affiliations
1
Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
2
Maryland Laser Skin and Vein Institute, Hunt Valley, Maryland.
3
Department of Dermatology, University of Maryland School of Medicine, Baltimore, Maryland.
PMID:
37389913
DOI:
10.1097/DSS.0000000000003868
No abstract available
MeSH terms
Bimatoprost / adverse effects
Humans
Hypopigmentation* / chemically induced
Iatrogenic Disease
Lasers, Solid-State* / adverse effects
Melanosis* / etiology
Melanosis* / therapy
Skin
Treatment Outcome
Substances
Bimatoprost